Surgery News and Research

RSS

Decade-long study demonstrates immediate, long-term benefits of holmium laser treatment for enlarged prostate

New research presented at the Annual Meeting of the American Urology Association (AUA) in Washington, DC demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia (BPH) - an enlargement of the prostate that affects most men as they age.

21 May 2011

FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas

The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

21 May 2011

Study examines long-term GI complications in childhood cancer survivors

Individuals who are treated for cancer during childhood have a significantly higher risk of developing gastrointestinal complications - from mild to severe - later in life, according to a study led by the University of California, San Francisco. The findings underscore the need for childhood cancer survivors and their physicians to be aware of these risk factors to ensure patients' ongoing health care needs are met.

21 May 2011

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

The way that clinicians report outcomes of surgery for a traumatic nerve injury involving the arm is not standardized, and it is thus difficult to compare the efficacy of different surgical treatments, according to a study by researchers at Hospital for Special Surgery (HSS) in New York.

20 May 2011

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.

20 May 2011

Curcumin compound can help head and neck cancer cells overcome resistance to chemotherapy drugs

A primary reason that head and neck cancer treatments fail is the tumor cells become resistant to chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive Cancer Center have found that a compound derived from the Indian spice curcumin can help cells overcome that resistance.

20 May 2011

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the CoreValve System from Medtronic, Inc. across seven international clinical registries.

From Medtronic 20 May 2011

Electrical disturbances in injured brain lead to poor recovery

Electrical disturbances that spread through an injured brain like tsunamis have a direct link to poor recovery and can last far longer than previously realized, researchers at the University of Cincinnati Neuroscience Institute have found.

20 May 2011

Surgeon's choices and choice of surgeons influence hospital charges for spinal fusion surgery

Hospital charges for spinal fusion surgery in the upper spine vary considerably—with the surgeon's choice of spinal hardware being the largest source of variation, reports a study in the May 15 issue of Spine.

20 May 2011

RTOG reports on largest trial for newly diagnosed glioblastoma

RTOG reports on the largest trial to-date for patients with newly diagnosed glioblastoma demonstrating the importance and feasibility of prospective molecular analysis of tumor tissue although finding that patients received no additional benefit from dose-intensive temozolomide as compared to standard adjuvant temozolomide after combined temozolomide and radiotherapy.

20 May 2011

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti Stem for shoulder joint replacement surgery.

20 May 2011

HealthGrades identifies major flaws in hospital ratings study

The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.

20 May 2011

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

For my money, the most interesting thing about Mitt Romney's health-care speech last week wasn't his struggle to defend Romneycare and distance it from Obamacare, but the largely hostile reception of the speech from the right.

20 May 2011

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, in Russia at the State Budgetary Healthcare Institution of Sverdlovsk Region - Sverdlovsk Regional Oncology Center in Ekaterinburg, Russia.

20 May 2011

Advantagene reaches SPA agreement with FDA for ProstAtak Phase 3 trial to prevent prostate cancer recurrence

Advantagene, Inc., a Massachusetts-based biopharmaceutical company, announced today that it reached an agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment (SPA) for a pivotal Phase 3 clinical trial of ProstAtak™, its lead agent for patients with newly diagnosed prostate cancer.

19 May 2011

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs.

19 May 2011

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Use of a simple, at-home screening test by Canadians can prevent many unnecessary colorectal cancer deaths, according to a special report about colorectal cancer in Canadian Cancer Statistics 2011 released today by the Canadian Cancer Society, in collaboration with the Public Health Agency of Canada and Statistics Canada.

19 May 2011

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Medtronic, Inc. today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve System, delivered through a new approach beneath the collarbone, achieved excellent procedural success rates and low in-hospital complication rates.

From Medtronic 19 May 2011

Hospital websites use industry-provided content and overestimate claims of surgical robots

An estimated four in 10 hospital websites in the United States publicize the use of robotic surgery, with the lion's share touting its clinical superiority despite a lack of scientific evidence that robotic surgery is any better than conventional operations, a new Johns Hopkins study finds.

19 May 2011

Thirty endoscopy units earn ASGE recognition for safety and quality

The American Society for Gastrointestinal Endoscopy has recognized 30 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

19 May 2011

Surgery News and Research

Decade-long study demonstrates immediate, long-term benefits of holmium laser treatment for enlarged prostate

FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas

Study examines long-term GI complications in childhood cancer survivors

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Curcumin compound can help head and neck cancer cells overcome resistance to chemotherapy drugs

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

Electrical disturbances in injured brain lead to poor recovery

Surgeon's choices and choice of surgeons influence hospital charges for spinal fusion surgery

RTOG reports on largest trial for newly diagnosed glioblastoma

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

HealthGrades identifies major flaws in hospital ratings study

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

Advantagene reaches SPA agreement with FDA for ProstAtak Phase 3 trial to prevent prostate cancer recurrence

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Hospital websites use industry-provided content and overestimate claims of surgical robots

Thirty endoscopy units earn ASGE recognition for safety and quality

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News